you, Good everyone. Thank Curt. morning,
X. a in of higher We and QX are first and guidance with EBITDA X, the our improvement cash detailed on solid generation. end at quarter delivered results range X Our Slides excellent
And largely Market was XX%, in by above quarter to consistent Volume application. in of quarters. until we've driven continued closer conditions the purchases the the with the the and we in were end range. would some EBITDA XX% prior midpoint end anticipated. by timing range guidance magnitude prior per declined returns behavior in as have share high reduction not declined sales Argentina, revenue in negotiated year for observed versus and earnings if quarter destocking of in lower volume grower delay line We first of our guidance. channel First X period. change the with to the The our guidance delivered of the been is
we reported addition, a versus free In in improvement period. the flow very prior year cash significant
net from actions, year. expect million to earnings to inflation restructuring of targeted million the of Our we deliver this benefited still and $XX savings $XX
sales at a XX% period. was lower our sales detail due provides X level. essentially North prior Slide year against volume to on declined Price America regional a flat. record
which fluindapyr. introduced fungicides, strong years, the is last which the is active Adastrio, based flutriafol; on including products versus NPI, resilience based with Xyway, greater our showed New portfolio launched region's the of or growth in and on newly rest ingredient, in X
of reported from to down returns were our FX. excluding in a countries most Am and of in Turning Latin least regions. was lower distribution the Volume volume included America. XX%, X the a Argentina, Sales decline Lat relationship. in XX%, negotiated resulting change decline
digits performed recently in our continued grew and well. by Branded double insecticide aided brands. Premio launched products growth differentiated Cyazypyr portfolio the diamides Our of the Star
Onsuva is including sales growth, strong based on of reported products fungicide, New fluindapyr. which
the most outperformed the were essentially in Australia weather. China Pricing was portfolio, sales the sales the in driver weather of destocking declined Overwatch single including was high based driven limited significant in Sales Isoflex. applications. year lower primary XX%, poor digits. excluding by dry herbicide continues, and the Asia to XX% the on channel Reduced volume of NPI India rest FX. pressure although prior with in flat downturn
of a more and grow FX, excluding registration A including weather by of low notably by Poland, We partially primarily than from volume, Adjusted the EMEA XX%, period, parts restructuring moderate volume declined primarily our headwinds and sales Italy offset driven in price. were and the headwinds. rationalization was year were lower due XX% COGS other Europe, France, removals contributions prior poor and Europe. from and Costs favorable offset EBITDA actions price lower input by a lower-margin with XX%, increases. to than U.K. Spain. Northern costs FX other lesser single-digit decline products in most degree, volume to did significant of headwind and
changes moved includes Slide on we we'll quickly making how in actions. We've strategic way investment strong continue reducing as we plant in model, our and areas and R&D to where without restructuring we rightsize our made spend. remain detail indirect transform to progress, These have We're and organized, pipeline. been organization X health operate our and the work. our further diligent operating including sacrificing such our and cost are
Restructuring quarter. provided significant year-on-year savings in the first
reflected QX progresses, the comparisons compared taken to cost through in we will the in year expect prior include actions resulted QX spending. an QX. cost limit XXXX year in will outsized As saving what prior in This be to our versus year
million deliver inflation cost to million in to our range costs. savings of to within impacts tracking $XX our net $XX XXXX, operating are any We
round of the The robust realized $XXX XXXX. to by well. anticipate mix a now and financial end interest been Global We both There of business bid the continue has significant rate from sponsors. Specialty to of savings of a progressing of buyers be our strategic Solutions is process. sale in run second million We're
this business be year. to the We the towards sale the of of expect end completed
QX full Slides X outlook. and X cover FMC's year and earnings
the favorable are see been Data from in ag actions outlook has positive industry. The a Overall, which as peak of year the third has many in steady come product in incomes well Generally unchanged. countries, that led the speaking, commercial teams but parties Grower our input application from Our to levels, of fundamentals from business inventory healthy remains as on have making are with basis, America ground. countries. down we to reduce full these pace operate lower-than-normal inventories our targeting the varied. reduction progress. strong. channel see condition, weather grower a remained most while inventories level the their is good similar destocking North is still levels. now level of in working at both to with and weather. are In hit retail a by our furthest distributors to of We at in inventory. along unfavorable customers EMEA are regional countries geographies, except On back normal, shows
materially trend to through normal more are as inventories America, and the lower levels the Latin of expected are In rest year. towards move we
Asia, parts but made We expect persist to Pakistan, strong destocking destocking in in have such into and ASEAN well as India QX. progress XXXX, of
the customers While encouraged patterns. are to return starting signs these activities that costs, continue to historical to by first we're run their order
North the continue for now the of depleted. In in products inventories indicates such current used which orders products we to America, have be that receive season, that will early been
In season's last Brazil, next year. customers we not are that now volumes did visibility discussing have providing
improves seek progresses, to of assumes outlook full year but the lower inventory. Our market the hold levels will as year customers the that
second our year. quarter forecasting be prior to are results similar the We to
during of digits by the volume to $X.XX improvement billion midpoint, expect a the to the mid-single which is low Price between is higher report be year-over-year first represents an This destocking. since in FX the start headwind quarter be outlook anticipated in global to and neutral. we growth to X% which is at year-on-year a billion, volume. of and $X expected are driven Sales the
of customers the outlook Our and in inventory assumes countries continue the growth maintain significant volume forecasting we're many levels from quarter products. coming a to in amount new reduce with
At These Brazil, due fungicide X% year we in the is fungicide Adjusted Argentina of and include midpoint, million, offset lower the earnings and the an in Germany. and share and EBITDA quarter expected million JORDI be Coragen expect midpoint. expense U.S. to and Star that lower $X.XX, will between the and be U.S., price at between COGS insecticide at eVo by the versus XX% growth per $XXX to restructuring expected volume prior the insecticide mainly in up headwinds. second and is in D&A. be increase in the $XXX benefits $X.XX interest midpoint, to Adastrio Premio EBITDA
growth on Onsuva new Slide from X.X% in with market at of Isoflex We're expected is Star in expected our throughout between from major unchanged update. Volume with in be Sales year QX an countries come and last amount midpoint. in insecticide billion, conditions from We also full and insecticide our half and to are of herbicide Brazil other is the which increase products coming provides growth formulations to from $X.X and the the strong financial to Brazil, forecasted improving outlook, a Australia, substantial Argentina anticipate the second products. launch $X.X new X Argentina Coragen between benefit growth billion contributions diamide and and Australia to Asia. and QX excited active eVo U.S., Premio new in in Argentina. fungicide the in Indonesia
for pricing half. be is the the in with year expected minor full pressure FX expect impact moderate headwind. first a We largest to the
midpoint to to increase Our EBITDA the growth outlook COGS per share remains share, by price is D&A. X% from be interest $X.XX to midpoint. and XXXX billion, and of benefits and $X.XX Volume headwinds. be is and expected an lower per at earnings the at restructuring Adjusted offset essentially forecasted which are lower million flat between $XXX to expense $X.XX
we've the growth achievable. and Slide deliver on second XXXX considering delivered in basis, year and outsized that X growth comparison, EBITDA basis low of XXXX. and the illustrates second in the XX% of range half but our dollar half an a is percentage the both in implied the to of growth and XXXX guidance. Revenue are required EBITDA sales midpoint in the may implied revenue absolute EBITDA we full XX% a appear on half growth The second of believe
and to We progress in we throughout conditions more expect as conditions normal improving XXXX. the year transition market
various of the the factors XX guidance variable. our EBITDA improving timing impact and remains magnitude the that biggest The outlines conditions Slide market results range. will within
Our half. market we recovery But improvement expectation the by broadly is meaningful in in region. that second conditions speaking, will vary anticipate
new expect trend will to sales, show products which continue is for a in resilience We demonstrated quarters. several greater they've
favorable comps flat that will pricing shift mainly to be We material year, in half. the stay we raw and as more the half modest a costs first in second the also for anticipate headwind, the
benefits what our delivering also we As million of the restructuring confident to not products new we're million ability $XX directly $XX for launch in to only successfully XXXX. but in in control,
call With I'll items. to details the turn that, over other and on cover cash flow Andrew to